Toyota Motor Corp. has stated it is not facing any immediate chip shortages following China’s recent export restrictions involving Dutch chipmaker Nexperia. However, Chief Executive Koji Sato noted the company is closely monitoring potential risks that could affect production. Speaking at the Japan Mobility Show in Tokyo, Sato said, “There’s some risk, but it’s not like we’re facing shortages tomorrow.”
While the Nexperia export ban could eventually impact output, Toyota—the world’s largest automaker—does not anticipate a sudden supply crunch. The industry has been on alert as automakers worldwide scramble to secure semiconductor supplies and assess inventory levels amid growing concerns about a tightening chip market.
China’s decision to ban exports of Nexperia’s products came after the Dutch government seized control of the company last month over national security concerns tied to its Chinese parent, Wingtech. The U.S. has also flagged Wingtech as a potential technology transfer risk.
Sato added that Japanese automakers are working together to standardize legacy semiconductors, a strategy aimed at preventing the severe disruptions experienced during the pandemic when reliance on custom chips left manufacturers vulnerable. Meanwhile, Nissan recently said it has enough chip inventory to last until early November without disruption.
In separate comments, Sato confirmed that Toyota has no plans to revise the tender offer price for Toyota Industries as part of its ongoing buyout. The group plans to take Toyota Industries private through a holding company backed by Toyota Motor, Toyota Fudosan, and Chairman Akio Toyoda.
The 16,300 yen ($108.10) per share offer has faced criticism from investors who argue it undervalues the company. Sato emphasized that Toyota will maintain transparency throughout the process, ensuring that minority shareholders’ interests are respected while seeking broad stakeholder understanding.


Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Washington Post Publisher Will Lewis Steps Down After Layoffs 



